Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

Molecular and Cellular Biology

Volumn 16, Issue 3, 1996, Pages 1115-1125

  Jeffers, Michael ^a   Rong, Sing ^a   Vande Woude, George F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; UROKINASE;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CARCINOGENICITY; EFFECTOR CELL; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESENCHYME CELL; METASTASIS; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0030039519     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.3.1115     Document Type: Article

References (57)

1. Andreasen, P. A., L. S. Nielsen, P. Kristensen, J. Grondahi-Hansen, L. Skriver, and K. Dano. 1986. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. J. Biol. Chem. 261:7644-7651.
2. Barbacid, M., J. R. Stephenson, and S. A. Aaronson. 1976. Structural polypeptides of mammalian type C RNA viruses: isolation and immunologic characterization of a low molecular weight polypeptide, p10. J. Biol. Chem. 251:4859-4866.
3. Bellusci, S., G. Moens, G. Gaudino, P. Comoglio, T. Nakamura, J.-P. Thiery, and J. Jouanneau. 1994. Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099.
4. Bhargava, M., A. Joseph, J. Knesel, R. Halaban, Y. Li, S. Pang, I. Goldberg, E. Setter, M. A. Donovan, R. Zarnegar, G. A. Michalpoulos, T. Nakamura, D. Faletto, and E. M. Rosen. 1992. Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ. 3:11-20.
5. Birkedal-Hansen, H., W. G. I. Moore, M. K. Bodden, L. J. Windsow, B. Birkedal-Hansen, A. DeCarlo, and J. A. Eagle. 1993 Matrix metalloproteinases, a review. Crit. Rev. Oral Biol. Med. 42:197-250
6. Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (London) 375:768-771.
7. Blair, D. G., C. S. Cooper, M. K. Oskarsson, L. A. Eader, and G. F. Vande Woude. 1982. New method for detecting cellular transforming genes. Science 218:1122-1125
8. Blasi, F. 1993. Urokinase and urokinase receptor a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111.
9. Bussolino, F., R. M. Di, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and P. M. Comoglio. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 119:629-641.
10. Cesarman, G. M., C. A. Guevara, and K. A. Hajjar. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). J. Biol. Chem. 269:21198-21203.
11. Chan, A. M., J. S. Rubin, D. P. Bottaro, D. W. Hirschfield, M. Chedid, and S. A. Aaronson. 1991. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 254:1382-1385
12. Cooper, C. S., M. Park, D. G. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (London) 311:29-33.
13. De Petro, G., A. Copeta, and S. Barlati. 1994. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res. 213:286-294.
14. Ellis, V., C. Pyke, J. Eriksen, H. Solberg, and K. Dano. 1992. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann. N. Y. Acad. Sci. 667:13-31
15. Ferracini, R., M. F. DiRenzo, K. Scotlandi, N. Baldini, M. Olivero, P.-L. Lollini, O. Cremona, M. Campanacci, and P. M. Comoglio. 1995 The Met/ HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10:739-749.
16. Gherardi, E., M. Sharpe, K. Lane, A. Sirulnik, and M. Stoker. 1993. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Symp. Soc. Exp. Biol. 47:163-181.
17. Giordano, S., Z. Zhen, E. Medico, G. Gaudino, F. Galimi, and P. M. Comoglio. 1993. Transfer of mitogenic and invasive response to scatter factor: hepatocyte growth factor by transfection of human MET protooncogene. Proc. Natl. Acad. Sci. USA 90:649-653.
18. Grant, D. S., H. K. Kleinman, I. D. Goldberg, M. M. Bhargava, B. J. Nickloff, J. L. Kinsella, P. Polverini, and E. M. Rosen. 1993 Scatter factor induces blood vessel formation in vivo Proc. Natl. Acad. Sci. USA 90:1937-1941.
19. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114-123.
20. Hajjar, K. A., A. T. Jacovina, and J. Chacko. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator. J. Biol Chem. 269: 21191-21197.
21. Hartmann, G., L. Naldini, K. M. Weidner, M. Sachs, E. Vigna, P. M. Comoglio, and W. Birchmeier. 1992. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc. Natl. Acad. Sci. USA 89:11574-11578.
22. Higashio, K., and N. Shima. 1993. Tumor cytotoxic activity of HGF/SF Exper Suppl. 65:351-368.
23. Kenworthy, P., P. Dowrick, J. H. Baillie, B. McCann, H. Tsubouchi, N. Arakaki, Y. Daikuhara, and R. M. Warn. 1992. The presence of scatter factor in patients with metastatic spread to the pleura. Br. J. Cancer 66:243-247.
24. Matsumoto, K., and T. Nakamura. 1992 Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions Crit. Rev. Oncog. 3:27-54.
25. Matsumoto, K., and T. Nakamura. 1993. Roles of HGF as a pleiotropic factor in organ regeneration. Birkhauser-Verlag, Basel.
26. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
27. Naldini, L., L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, W. Birchmeier, Y. Daikuhara, H. Tsubouchi, F. Blasi, and P. M. Comoglio. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor EMBO J. 11:4825-4833.
28. Nusrat, A., C. A. Parkos, A. E. Bacarra, P. J. Godowski, C. Delp-Archer, E. M. Rosen, and J. L. Madara. 1994. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium J. Clin. Invest. 93:2056-2065
29. Odekon, L. E., F. Blasi, and D. B. Rifkin. 1994 Requirement for receptor-hound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 158:398-407.
30. Odekon, L. E., Y. Sato, and D. B. Rifkin. 1992. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol. 150: 258-263.
31. Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. F. Vande Wonde. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad Sci. USA 84:6379-5383.
32. Pepper, M. S., K. Matsumoto, T. Nakamura, L. Orci, and R. Montesano. 1992. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 267:20493-20496.
33. Ponting, C. P., J. M. Marshall, and S. A. Cederholm-Williams. 1992. Plasminogen, a structural review Blood Coagul Fibrinolysis 3:605-614.
34. Rong, S., M. Bodescot, D. Blair, J. Dunn, T. Nakamura, K. Mizuno, M. Park, A. Chan, S. Aaronson, and G. F. Vande Woude. 1992. Tumongenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 12:5152-5158.
35. Rong, S., L. A. Donehower, M. F. Hansen, L. Strong, M. Tainsky, M. Jeffers, J. H. Resau, E. Hudson, I. Tsarfaty, and G. F. Vande Woude. 1995. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res. 55:1963-1970.
36. Rong, S., M. Jeffers, J. H. Resau, I. Tsarfaty, M. Oskarsson, and G. F. Vande Woude. 1993. Met expression and sarcoma tumorigenicity. Cancer Res. 53: 5355-5360.
37. Rong, S., M. Oskarsson, D. L. Faletto, I. Tsarfaty, J. Resau, T. Nakamura, E. Rosen, R. Hopkins, and G. F. Vande Wonde. 1993 Tumorigenesis induced by co-expression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ. 4:563-569.
38. Rong, S., S. Segal, M. Anver, J. H. Resau, and G. F. Vande Wonde. 1994 Invasiveness and metastasis of NIH/3T3 cells induced by Met-HGF/SF autocrine stimulation Proc. Natl. Acad. Sci. USA 91:4731-4735.
39. Rosen, E. M., J. Knesel, I. D. Goldberg, L. Jin, M. Bhargava, A. Joseph, R. Zitnik, J. Wines, M. Kelley, and S. Rockwell. 1994. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J Cancer 57:706-714.
40. Rubin, J. S., D. P. Bottaro, and S. A. Aaronson. 1993. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta 1155:357-371.
41. Saksela, O., and D. B. Rifkin. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4:93-126.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Santos, O. F. P., E. J. G. Barros, X.-M. Yang, K. Matsumoto, T. Nakamura, M. Park, and S. K. Nigam. 1994. Involvement of hepatocyte growth factor in kidney development. Dev. Biol. 163:525-529.
44. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeier. 1995 Scatter factor/hepatocyte growth factor is essential for liver development Nature (London) 373:699-702.
45. Sonnenberg, E., D. Meyer, K. M. Weidner, and C. Birchmeier. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235.
46. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
47. Stetler-Stevenson, W. G., S. Aznavoorian, and L. A. Liotta. 1993. Tumor cell intetactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-573.
48. Stoker, M., E. Gherardi, M. Perryman, and J. Gray. 1987. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (London) 327:239-242.
49. Stoppelli, M. P., C. Tacchetti, M. V. Cubelus, A. Corti, V. J. Hearing, G. Cassani, E. Appella, and F. Blasi. 1986. Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 45:675-684.
50. Streit, A., C. D. Stern, C. Thery, G. W. Ireland, S. Aparicio, M. J. Sharpe, and E. Gherardi. 1995 A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development 121:813-824.
51. Tsarfaty, I., J. H. Resau, S. Rulong, I. Keydar, D. L. Faletto, and G. Vande Woude. 1992. The met proto-oncogene receptor and lumen formation. Science 257:1258-1261.
52. Tsarfaty, I., S. Rong, J. H. Resau, S. Rulong, P. Pinto da Silva, and G. F. Vande Woude. 1994. Met mediated signaling in mesenchymal to epithelial cell conversion. Science 263:98-101.
53. Tsuboi, R., and D. B. Rifkin. 1990. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int. J. Cancer 46:56-60.
54. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature (London) 373:702-705.
55. Vassalli, J.-D., and D. Belin. 1987. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 214:187-191.
56. Weidner, K. M., J. Behrens, J. Vandekerckhove, and W. Birchmeier. 1990. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:2097-2108.
57. Woolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble, and E. Gherardi. 1995 Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol 128:171-184.